Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Msci Inc (MSCI) vs Philip Morris International Inc. (PM) Price & Performance

Msci IncTrade
Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

Msci Inc vs Philip Morris International Inc. — how do they compare? Msci Inc trades at $562.98 (market cap $45.51B), while Philip Morris International Inc. trades at $190.1 (market cap $300.37B). The key difference: Philip Morris International Inc. is far larger — about 6.6× Msci Inc's market cap, and Philip Morris International Inc. pays the higher dividend (3.05%). Which is the better fit depends on your goals.

MSCIPM
Market Cap
$45.51B$300.37B
Sector
FinancialsConsumer Staples
52-Week High
$643.83$192.98
52-Week Low
$511.84$144.33
Enterprise Value
$51.67B$346.86B
Dividend Yield
1.31%3.05%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Msci Inc

MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.

Read more on MSCI

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Read more on PM